Role of renin-angiotensin system blockades in reciprocal relationship between insulin resistance and endothelial dysfunction

Hypertension

Volumn 56, Issue 6, 2010, Pages

  Koh, Kwang Kon ^a   Sakuma, Ichiro ^b   Quon, Michael J ^c  

^a Gachon University College of Medicine   (South Korea)

^b Hokko Memorial Hospital   (Japan)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ATENOLOL; CANDESARTAN; HYDROCHLOROTHIAZIDE; LOSARTAN; PLACEBO; RAMIPRIL; TELMISARTAN; VALSARTAN;

DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LETTER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT DURATION;

ADIPOKINES; ANTIHYPERTENSIVE AGENTS; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; INSULIN RESISTANCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENIN-ANGIOTENSIN SYSTEM;

EID: 78650414197     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.161869     Document Type: Letter

References (5)

1. Azekoshi Y, Yasu T, Watanabe S, Tagawa T, Abe S, Yamakawa K, Uehara Y, Momomura S, Urata H, Ueda S. Free fatty acid causes leukocyte activation and resultant endothelial dysfunction through enhanced angiotensin II production in mononuclear and polymorphonuclear cells. Hypertension. 2010;56: 136-142.
2. Kim J, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006;113:1888-1904.
3. Cole BK, Keller SR, Wu R, Carter JD, Nadler JL, Nunemaker CS. Val-sartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice. Hypertension. 2010;55:715-721.
4. He H, Yang D, Ma L, Luo Z, Ma S, Feng X, Cao T, Yan Z, Liu D, Tepel M, Zhu Z. Telmisartan prevents weight gain and obesity through activation of peroxisome proliferator-activated receptor-S-dependent pathways. Hypertension. 2010;55:869-879.
5. Koh KK, Quon MJ, Han SH, Lee Y, Kim SJ, Koh Y, Shin EK. Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs. Int J Cardiol. 2010;140:73-81.